9.02
price down icon4.25%   -0.40
after-market Dopo l'orario di chiusura: 9.05 0.03 +0.33%
loading
Precedente Chiudi:
$9.42
Aprire:
$9.45
Volume 24 ore:
112.31K
Relative Volume:
0.94
Capitalizzazione di mercato:
$130.05M
Reddito:
$166.88M
Utile/perdita netta:
$-74.18M
Rapporto P/E:
-1.7791
EPS:
-5.07
Flusso di cassa netto:
$1.14M
1 W Prestazione:
-0.55%
1M Prestazione:
+7.38%
6M Prestazione:
-33.68%
1 anno Prestazione:
-64.28%
Intervallo 1D:
Value
$9.00
$9.465
Intervallo di 1 settimana:
Value
$9.00
$9.58
Portata 52W:
Value
$7.8701
$25.65

Anika Therapeutics Inc Stock (ANIK) Company Profile

Name
Nome
Anika Therapeutics Inc
Name
Telefono
(781) 457-9000
Name
Indirizzo
32 WIGGINS AVENUE, BEDFORD, MA
Name
Dipendente
288
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-12
Name
Ultimi documenti SEC
Name
ANIK's Discussions on Twitter

Confronta ANIK con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
ANIK
Anika Therapeutics Inc
9.02 135.82M 166.88M -74.18M 1.14M -5.07
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
141.11 63.55B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.71 44.47B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.00 40.17B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.03 22.99B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
440.00 20.14B 3.08B 1.24B 1.07B 25.61

Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-17 Iniziato B. Riley Securities Buy
2024-11-01 Reiterato Barrington Research Outperform
2023-08-14 Aggiornamento Barrington Research Mkt Perform → Outperform
2023-03-07 Downgrade Barrington Research Outperform → Mkt Perform
2022-11-09 Aggiornamento Barrington Research Mkt Perform → Outperform
2022-10-14 Ripresa Stephens Equal-Weight
2022-03-09 Downgrade Barrington Research Outperform → Mkt Perform
2022-03-09 Downgrade Stephens Overweight → Equal-Weight
2021-11-16 Iniziato Stephens Overweight
2021-07-16 Iniziato UBS Neutral
2020-12-16 Aggiornamento Barrington Research Mkt Perform → Outperform
2020-05-08 Downgrade Barrington Research Outperform → Mkt Perform
2020-01-21 Aggiornamento Sidoti Neutral → Buy
2020-01-10 Aggiornamento First Analysis Sec Outperform → Strong Buy
2019-11-05 Iniziato BWS Financial Sell
2019-09-24 Reiterato Barrington Research Outperform
2019-09-23 Downgrade First Analysis Sec Strong Buy → Outperform
2019-07-25 Aggiornamento First Analysis Sec Neutral → Strong Buy
2019-02-22 Downgrade First Analysis Sec Outperform → Neutral
2019-02-22 Downgrade Sidoti Buy → Neutral
2018-07-27 Aggiornamento Barrington Research Mkt Perform → Outperform
2018-06-20 Downgrade Barrington Research Outperform → Mkt Perform
2018-06-20 Downgrade First Analysis Sec Overweight → Equal-Weight
2018-05-04 Aggiornamento Barrington Research Mkt Perform → Outperform
2018-02-23 Downgrade Barrington Research Outperform → Mkt Perform
2018-01-24 Aggiornamento First Analysis Sec Equal-Weight → Overweight
2017-10-27 Reiterato Barrington Research Outperform
2016-05-09 Aggiornamento Singular Research BUY - Long-Term → Buy
2016-04-27 Downgrade Northland Capital Outperform → Market Perform
2016-02-26 Reiterato Barrington Research Outperform
Mostra tutto

Anika Therapeutics Inc Borsa (ANIK) Ultime notizie

pulisher
05:11 AM

Anika Therapeutics Inc. stock trend outlook and recovery path2025 Short Interest & Community Consensus Picks - newser.com

05:11 AM
pulisher
Oct 09, 2025

ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. - GlobeNewswire

Oct 09, 2025
pulisher
Oct 09, 2025

United States Adhesion Barrier Market Set for Explosive Growth: - openPR.com

Oct 09, 2025
pulisher
Oct 09, 2025

Can Anika Therapeutics Inc. (AKP) stock sustain double digit ROEJuly 2025 Closing Moves & Scalable Portfolio Growth Ideas - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Weiss Ratings Reiterates "Sell (E+)" Rating for Anika Therapeutics (NASDAQ:ANIK) - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Orthopedic Digit Implants Market Report 2025-2033, with Profiles of Extremity Medical, Stryker, Zimmer, Smith & Nephew, Depuy, Arthrex, Acumed, Anika Therapeutics, VILEX, and Paragon 28 - Ortho Spine News

Oct 08, 2025
pulisher
Oct 08, 2025

Orthopedic Digit Implants Market Report 2025-2033, with - GlobeNewswire

Oct 08, 2025
pulisher
Oct 05, 2025

What technical models suggest about Anika Therapeutics Inc.’s comebackM&A Rumor & Stock Portfolio Risk Control - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 06:33:40 - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Predicting Anika Therapeutics Inc. trend using moving averagesJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Anika Therapeutics Inc. stock trendline breakdownEarnings Recap Report & Fast Gaining Stock Reports - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Trend analysis for Anika Therapeutics Inc. this weekFed Meeting & Risk Managed Investment Entry Signals - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Leading vs lagging indicators on Anika Therapeutics Inc. performanceM&A Rumor & Real-Time Sentiment Analysis - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Analyzing Anika Therapeutics Inc. with multi timeframe chartsMarket Sentiment Report & Community Verified Trade Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Anika Therapeutics Inc. (AKP) stock attractive for growth fundsRisk Management & Real-Time Chart Breakout Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Using data filters to optimize entry into Anika Therapeutics Inc.New Guidance & High Conviction Investment Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Multi factor analysis applied to Anika Therapeutics Inc.M&A Rumor & Safe Investment Capital Preservation Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 01:07:01 - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How to monitor Anika Therapeutics Inc. with trend dashboardsEarnings Trend Report & High Conviction Investment Ideas - newser.com

Oct 03, 2025
pulisher
Sep 29, 2025

What analysts say about Anika Therapeutics Inc stockMean Reversion Trades & Big Gains Small Investment - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

Can T I Global Limited Survive Disruption in Its Core IndustryRSI Overbought/Oversold & Double Digit Trading Ideas - earlytimes.in

Sep 29, 2025
pulisher
Sep 28, 2025

What drives Anika Therapeutics Inc stock priceVolume Spike Alerts & Investment Recommendations You Can Trust - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Published on: 2025-10-03 05:32:20 - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Is Anika Therapeutics Inc AKP a good long term investmentPortfolio Diversification Tips & Capital Allocation Recommendations - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

Published on: 2025-09-27 05:01:43 - newser.com

Sep 27, 2025
pulisher
Sep 26, 2025

What analysts say about Anika Therapeutics Inc AKP stockStop Loss Placement Tips & Exceptional Return Opportunities - Early Times

Sep 26, 2025
pulisher
Sep 25, 2025

ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire

Sep 25, 2025
pulisher
Sep 25, 2025

Anika Therapeutics Inc. $ANIK Stock Position Reduced by Goldman Sachs Group Inc. - Defense World

Sep 25, 2025
pulisher
Sep 23, 2025

Barrington Research Reiterates "Outperform" Rating for Anika Therapeutics (NASDAQ:ANIK) - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Anika Therapeutics (ANIK) Rating Maintained with $15 Target by B - GuruFocus

Sep 23, 2025
pulisher
Sep 23, 2025

Will Anika Therapeutics Inc. stock go up soonJuly 2025 Snapshot & Stock Portfolio Risk Control - newser.com

Sep 23, 2025
pulisher
Sep 23, 2025

Barrington Maintains Anika Therapeutics(ANIK.US) With Buy Rating, Maintains Target Price $15 - 富途牛牛

Sep 23, 2025

Anika Therapeutics Inc Azioni (ANIK) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Anika Therapeutics Inc Azioni (ANIK) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Nunes Anne
SVP, Chief Operations Officer
Mar 17 '25
Option Exercise
0.00
3,637
0
21,722
Colleran David
EVP, General Counsel, Corp Sec
Mar 17 '25
Option Exercise
0.00
6,448
0
49,847
Blanchard Cheryl R
President, CEO, Director
Mar 17 '25
Option Exercise
0.00
25,132
0
209,472
Nunes Anne
SVP, Chief Operations Officer
Mar 11 '25
Option Exercise
0.00
2,561
0
18,837
Colleran David
EVP, General Counsel, Corp Sec
Mar 11 '25
Option Exercise
0.00
7,663
0
45,649
Blanchard Cheryl R
President, CEO, Director
Mar 11 '25
Option Exercise
0.00
30,060
0
197,015
Nunes Anne
SVP, Chief Operations Officer
Mar 10 '25
Option Exercise
0.00
3,296
0
17,235
Colleran David
EVP, General Counsel, Corp Sec
Mar 10 '25
Option Exercise
0.00
5,465
0
39,590
Blanchard Cheryl R
President, CEO, Director
Mar 10 '25
Option Exercise
0.00
20,002
0
172,826
$19.76
price down icon 1.54%
$9.74
price down icon 2.50%
$53.95
price down icon 7.38%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.20%
$136.63
price down icon 1.33%
$440.00
price down icon 1.21%
Capitalizzazione:     |  Volume (24 ore):